-
1
-
-
0026785374
-
Views of a general population on mass screening for colorectal cancer: The Burgundy study
-
Arveux P, Durand G, Milan C et al. Views of a general population on mass screening for colorectal cancer: the Burgundy study. Prev Med 1992;21:574-81
-
(1992)
Prev Med
, vol.21
, pp. 574-581
-
-
Arveux, P.1
Durand, G.2
Milan, C.3
-
2
-
-
0001977641
-
Survival of cancer patients in Europe. The Eurocare study
-
Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J. Survival of cancer patients in Europe. The Eurocare study. IARC Sci Publ 19951:132
-
(1995)
IARC Sci Publ
, vol.1
, pp. 132
-
-
Berrino, F.1
Sant, M.2
Verdecchia, A.3
Capocaccia, R.4
Hakulinen, T.5
Esteve, J.6
-
4
-
-
0026849744
-
Vécu d'une campagne de dépistage de masse des cancers colorectaux par les médecins généralistes
-
Durand G, Arveux P, Milan C, Quelier C, Bedenne L, Faivre J. Vécu d'une campagne de dépistage de masse des cancers colorectaux par les médecins généralistes. Cah Sociol Démogr Méd 1992;22:197-206
-
(1992)
Cah Sociol Démogr Méd
, vol.22
, pp. 197-206
-
-
Durand, G.1
Arveux, P.2
Milan, C.3
Quelier, C.4
Bedenne, L.5
Faivre, J.6
-
5
-
-
0022476672
-
Secondary prevention of cancer: An overview
-
Eddy DM. Secondary prevention of cancer: an overview. Bull WHO 1986;64:421-9
-
(1986)
Bull WHO
, vol.64
, pp. 421-429
-
-
Eddy, D.M.1
-
6
-
-
34447113862
-
Participation in mass screening for colorectal cancer: Results of screening and rescreening from the Burgundy study
-
Faivre J, Arveux P, Milan C, Durand G, Lamour J, Bedenne LP. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur J Cancer Prev 1991;1:49-55
-
(1991)
Eur J Cancer Prev
, vol.1
, pp. 49-55
-
-
Faivre, J.1
Arveux, P.2
Milan, C.3
Durand, G.4
Lamour, J.5
Bedenne, L.P.6
-
7
-
-
0024382471
-
Randomised controlled trial a faecal occult blood screening for colorectal cancer. Results for first 17349 subjects
-
Hardcastle JD, Thomas WH, Chamberlain J et al. Randomised controlled trial a faecal occult blood screening for colorectal cancer. Results for first 17349 subjects. Lancet 1989; i:1160-4
-
(1989)
Lancet
, vol.1
, pp. 1160-1164
-
-
Hardcastle, J.D.1
Thomas, W.H.2
Chamberlain, J.3
-
8
-
-
0023721838
-
Screening and rescreening for colorectal cancer. A controlled trial of fecal occult 17 blood testing in 27 700 subjects
-
Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult 17 blood testing in 27 700 subjects. Cancer 1988;62:645-51
-
(1988)
Cancer
, vol.62
, pp. 645-651
-
-
Kewenter, J.1
Bjork, S.2
Haglind, E.3
Smith, L.4
Svanvik, J.5
Ahren, C.6
-
9
-
-
0024403401
-
Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark
-
Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol 1989;24:599-606
-
(1989)
Scand J Gastroenterol
, vol.24
, pp. 599-606
-
-
Kronborg, O.1
Fenger, C.2
Olsen, J.3
Bech, K.4
Sondergaard, O.5
-
10
-
-
0021276870
-
Screening for asymptomatic bowel cancer in general practice
-
Lallemand RC, Vakil PA, Pearson P, Box V. Screening for asymptomatic bowel cancer in general practice. Br Med J 1984;288:31-3
-
(1984)
Br Med J
, vol.288
, pp. 31-33
-
-
Lallemand, R.C.1
Vakil, P.A.2
Pearson, P.3
Box, V.4
-
11
-
-
85066729229
-
Faecal occult blood tests: Choice, usage and clinical applications
-
Lang CA, Ransohoff DF. Faecal occult blood tests: choice, usage and clinical applications. JAMA 1992;271:1011-3
-
(1992)
JAMA
, vol.271
, pp. 1011-1013
-
-
Lang, C.A.1
Ransohoff, D.F.2
-
12
-
-
0026768587
-
Les cancers digestifs en France. Comparaison de l'incidence dans sept départements et estimation de l'incidence pour la France entière
-
Launoy G, Grosclaude P, Pienkowski P et al. Les cancers digestifs en France. Comparaison de l'incidence dans sept départements et estimation de l'incidence pour la France entière. Gastroenterol Clin Biol 1992;16:633-8
-
(1992)
Gastroenterol Clin Biol
, vol.16
, pp. 633-638
-
-
Launoy, G.1
Grosclaude, P.2
Pienkowski, P.3
-
13
-
-
9544253113
-
Le dépistage de masse du cancer colorectal en France. Expérience auprès de 165 000 personnes dans le Calvados
-
sous presse
-
Launoy G, Herbert C, Vallee JP et al. Le dépistage de masse du cancer colorectal en France. Expérience auprès de 165 000 personnes dans le Calvados. Gastroenterol Clin Biol (sous presse)
-
Gastroenterol Clin Biol
-
-
Launoy, G.1
Herbert, C.2
Vallee, J.P.3
-
14
-
-
0029449738
-
A case-control study to evaluate efficacy of screening for faecal occult blood
-
Lazovich D, Weiss NS, Stevens NG, White E, McKnight B, Wagner EH. A case-control study to evaluate efficacy of screening for faecal occult blood. J Med Screening 1955;2: 84-9
-
(1955)
J Med Screening
, vol.2
, pp. 84-89
-
-
Lazovich, D.1
Weiss, N.S.2
Stevens, N.G.3
White, E.4
McKnight, B.5
Wagner, E.H.6
-
15
-
-
0027223762
-
Reducing mortality from colorectal cancer by screening for fecal occult blood
-
Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71
-
(1993)
N Engl J Med
, vol.328
, pp. 1365-1371
-
-
Mandel, J.S.1
Bond, J.H.2
Church, T.R.3
-
16
-
-
9544249551
-
La stratégie actuelle de détection des polypes peut-elle faire baisser l'incidence du cancer de l'intestin?
-
Ducimetière P, Montaville B, Schaffer P, Spira N, éds. Paris : Inserm
-
Moutet JP, Michiels C, Milan C, Hillon P, Faivre J. La stratégie actuelle de détection des polypes peut-elle faire baisser l'incidence du cancer de l'intestin? In: Ducimetière P, Montaville B, Schaffer P, Spira N, éds. Recherche et politique de santé. L'apport des registres de morbidité. Paris : Inserm, 1992:187-90
-
(1992)
Recherche et Politique de Santé. L'Apport des Registres de Morbidité
, pp. 187-190
-
-
Moutet, J.P.1
Michiels, C.2
Milan, C.3
Hillon, P.4
Faivre, J.5
-
17
-
-
0022649703
-
Randomised trial of compliance with screening for colorectal cancer
-
Nichols S, Koch E, Lallemand RC et al. Randomised trial of compliance with screening for colorectal cancer. Br Med J 1986;293:107-10
-
(1986)
Br Med J
, vol.293
, pp. 107-110
-
-
Nichols, S.1
Koch, E.2
Lallemand, R.C.3
-
18
-
-
0029010326
-
Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study
-
Saito H, Soma Y, Koeda J et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 1995;61:465-9
-
(1995)
Int J Cancer
, vol.61
, pp. 465-469
-
-
Saito, H.1
Soma, Y.2
Koeda, J.3
-
20
-
-
0027598544
-
Effectiveness of colorectal cancer screening: Results from a population-based case-control study in Saarland, Germany
-
Warhendorf J, Robra BP, Wiebelt H, Oberhausen R, Weiland M, Dhom G. Effectiveness of colorectal cancer screening: results from a population-based case-control study in Saarland, Germany. Eur J Cancer Prev 1993; 2:221-7
-
(1993)
Eur J Cancer Prev
, vol.2
, pp. 221-227
-
-
Warhendorf, J.1
Robra, B.P.2
Wiebelt, H.3
Oberhausen, R.4
Weiland, M.5
Dhom, G.6
-
21
-
-
0000876781
-
Faecal occult blood tests: Choice, usage and clinical applications
-
Young GP, St John DJB. Faecal occult blood tests: choice, usage and clinical applications. Clin Biochem Rev 1992;13: 161-7
-
(1992)
Clin Biochem Rev
, vol.13
, pp. 161-167
-
-
Young, G.P.1
St John, D.J.B.2
|